Last edited: October 30, 2026
In observational studies, low vitamin D levels and dementia are more frequently found to occur together. This does not automatically mean that supplemental vitamin D can prevent dementia. Controlled studies have not yet reliably demonstrated a general protective effect in the groups studied. However, treating a confirmed deficiency remains a sensible course of action in its own right. [1][6]
As Herbert Eder—an internationally sought-after frequency expert—I will explain why this distinction is important for health-related decisions. A reported correlation of 40 percent is not a guaranteed effect on intake and does not specify a dosage. Furthermore, when it comes to memory problems, it takes more than just focusing on a single lab value. [3][13]
Why Vitamin D Remains Important for Health
Vitamin D supports calcium metabolism and bone health. The body can produce it in the skin when exposed to UV-B radiation; only a small portion is typically obtained through food. For older adults who spend little time outdoors, supplemental intake may be particularly important. Whether a supplement is necessary should be determined based on the individual’s personal situation. The lack of protection against dementia does not make treating a confirmed deficiency unnecessary. [2]
So the question regarding the brain is not a matter of deciding whether vitamin D is „good“ or „bad“ overall. Rather, it is about what additional effects, beyond meeting nutritional needs, have been proven. This distinction helps avoid both unrealistic expectations and the premature discontinuation of a supplement prescribed for other reasons.
Where the Hope for Dementia Prevention Comes From
A widely cited 2023 study analyzed data from 12,388 people who were initially free of dementia, drawn from the U.S. National Alzheimer’s Coordinating Center. Documented vitamin D intake was associated with an approximately 40 percent lower rate of dementia. However, this was an observational study: Participants were not randomly assigned to a treatment or placebo group. The reported association therefore does not prove that vitamin D caused this difference. [3]
In addition, information on dosage, duration of use, baseline values, and individual sun exposure was lacking. Other differences between people who took the supplement and those who did not could not be fully accounted for either. The study provides a strong rationale for further research. However, it does not indicate a personal probability of success or a suitable dosage. The figure „40 percent“ should therefore not be presented as a guaranteed treatment effect on a package or during a consultation. [3]
A simple thought experiment highlights the problem: Would two otherwise comparable groups, after being randomly assigned, also develop the disease at different rates? Only then can the effect of the intervention be better distinguished from other characteristics of the participants. Observational data and controlled trials complement each other; they do not automatically answer the same question.
Vitamin D and Dementia in Controlled Studies
VITAL: No overall improvement in cognitive development
Two substudies of the large VITAL trial compared 2,000 International Units of vitamin D3 daily with a placebo. Cognitive tests were administered by telephone to 3,424 older adults and in person to an additional 794. Over a period of approximately two to three years, there was no overall confirmed benefit for the development of memory and other cognitive functions. A favorable finding in a subgroup of Black participants required further confirmation. The authors cautioned against deriving a general recommendation from these results at this stage. Furthermore, tested cognitive performance and dementia subsequently diagnosed are different endpoints. [4]
D-Health: Even High Monthly Single Doses Offer No Cognitive Benefit
The Australian D-Health study examined, among other things, a monthly dose of 60,000 International Units. In a randomly selected subgroup of participants aged 70 and older, telephone assessments were conducted after two and five years. A total of 3,887 people participated in the first survey. Neither the mean test performance nor the proportion of participants with cognitive impairment differed significantly between the vitamin D group and the placebo group. This study dose is a description of the trial and not a recommendation for self-medication. [5]
FIND: Dementia Diagnoses Instead of Just Test Scores
The Finnish study randomly assigned 2,492 people without known dementia to receive either a placebo, 1,600, or 3,200 International Units daily. Over an average of 4.2 years, 45 cases of dementia were recorded: 18 in the placebo group, 14 in the lower-dose group, and 13 in the higher-dose group. These differences were not statistically significant. Most participants were already receiving adequate care; furthermore, the number of cases was small. A weaker effect therefore cannot be ruled out with certainty. However, the results do not support a general recommendation for dementia prevention through the use of high doses. [1]
VitaMIND: What should be done in cases of mild to moderate deficiency?
One common objection is that studies have primarily examined well-nourished individuals. The VitaMIND study, published in 2025, therefore included a particularly interesting group: 620 adults aged 50 and older with mild to moderate vitamin D deficiency and early cognitive impairments. They received either vitamin D or a placebo for two years. The assessments were conducted primarily from home. No clear benefit was observed for the primary measure of executive function or for other measures of cognition, daily functioning, and well-being. [6]
This study, too, does not address every conceivable situation. It did not examine general treatment for advanced dementia, nor did it consider any specific duration or dosage. However, the results contradict the blanket assumption that even a mild deficiency explains memory problems and that compensating for it must improve cognitive function. The significance of a study should not be overstated, nor should its unfavorable results be ignored. [6]
When is a blood test recommended?
A vitamin D test should address a specific medical question. NICE does not recommend routine testing for everyone. Testing may be considered, for example, in cases of symptoms of deficiency, a very high risk of deficiency, or a corresponding clinical indication. This may include extremely limited sun exposure. Concerns about memory alone therefore do not justify an open-ended program of repeated laboratory tests with increasingly higher target levels. Discuss what a test result would actually change regarding the planned care or treatment. [7]
The Endocrine Society also advises against routine testing without a valid medical indication. For people aged 75 and older, it recommends supplementation based on empirical evidence due to potential benefits for life expectancy. This is not a recommendation for dementia prevention. If supplementation is used, the guideline favors lower daily doses over infrequent high single doses. [8]
Helpful questions to ask during the consultation include: Why is my level being measured? Is there a specific risk? What test result would trigger treatment? When would it make sense to have another checkup? This gives the lab result a clear purpose. Without such a purpose, a number can cause more uncertainty than it helps in making a decision.
How to Interpret Quantity Information Correctly
The German Nutrition Society recommends 20 micrograms per day for adults as an estimated value in cases where the body does not produce the vitamin on its own. This corresponds to 800 International Units. The important caveat is „in the absence of the body’s own production“: This value is not a blanket recommendation to take this additional amount daily, regardless of lifestyle and dietary intake. Nor is it a dose that has been tested for its effectiveness against dementia. Targeted supplementation may be necessary for people with limited mobility or who spend very little time outdoors. [9]
Review the complete list of products together: single-ingredient supplements, multivitamins, and, if applicable, a calcium-vitamin D combination. Note the amount per tablet or drop and the actual frequency of use for each. A clear list makes it easier to spot duplicates. The information on the front of a package isn’t always sufficient for this; what matters is the actual dose taken.
Sunlight: No One-Size-Fits-All Rule for Everyone
Vitamin D production depends, among other factors, on skin type, the season, and geographic location. Therefore, a fixed amount of sun exposure is not suitable for everyone. Sunburn should be avoided; using a tanning bed is not an appropriate way to increase vitamin D levels. In older adults and those who spend little time outdoors, the body’s ability to produce vitamin D may be further limited. [10]
More vitamin D isn't necessarily better
The EFSA specifies 100 micrograms of vitamin D per day as the tolerable upper intake level for adults from food and supplements. For standard vitamin D3, this corresponds to 4,000 International Units. This limit is not a recommendation to approach it. It represents a safety assessment for long-term intake. Medically indicated treatment for deficiency may require other time-limited regimens; it should therefore be part of an individualized treatment plan. [11]
A significant overdose can raise calcium levels and cause, among other things, nausea, intense thirst, frequent urination, muscle weakness, or confusion. Severe cases can damage the kidneys. Such risks arise primarily from taking excessive doses of the medication. Any new symptoms should be evaluated by a doctor. [12]
Memory problems require a more comprehensive evaluation
Forgetfulness does not automatically mean dementia. Depression, anxiety, thyroid problems, acute illnesses, and side effects from medications can cause similar symptoms. The evaluation therefore includes a discussion of your symptoms, a physical examination, and, depending on the situation, lab tests and memory tests. It would be too narrow an approach to focus solely on vitamin D. If these changes are affecting your daily life, schedule a medical evaluation and bring specific examples as well as a list of your medications with you. [13]
For example, write down when you first noticed the difficulties, in what situations they occur, and which tasks used to be easier. If you’d like, someone you trust can add their observations. This gives the conversation more substance than simply asking which dietary supplement is suitable for treating forgetfulness.
What You Can Do for Brain Health
In its guidelines updated in 2026, the WHO highlights several modifiable risk factors: physical activity, not smoking, limited alcohol consumption, a healthy diet, and social and mental engagement. Treating high blood pressure, diabetes, and high blood lipid levels, as well as ensuring appropriate hearing care, can also be part of reducing the risk. This does not guarantee that an individual will never develop dementia. However, it provides a broader and more well-founded approach than focusing on a single vitamin level. [14]
For your next appointment, choose two specific topics: one regarding your vitamin D intake and one regarding your actual memory concerns or risk factors. This will ensure that both topics are addressed appropriately. A supplement prescribed for a valid reason retains its place without needing to be advertised as having an effect that it has not yet reliably demonstrated.
View memory concerns from a broader perspective than just vitamin levels
When memory loss begins to affect daily life, specific examples and a complete list of medications can help with the evaluation. My article Understanding and Diagnosing Dementia describes the next steps. The overview Reducing the Risk of Dementia in Everyday Life classifies modifiable factors. Vitamin D status can be a health issue in its own right, but it is not a substitute for diagnostic testing or comprehensive preventive counseling. [13][14]
The same applies to frequency therapy: A change in a biomarker or a short-term improvement in a test result is not the same as proven prevention of dementia. Results must align with the claimed goal. The effectiveness of combining a vitamin with a device-based treatment cannot be proven simply because there are separate observations for both.
Therefore, address two issues separately: Is there a specific reason for taking vitamin D, and what should be investigated regarding the changes in memory? A supplement prescribed for other reasons should not be discontinued on one’s own simply because there is no evidence of dementia. Likewise, concerns about memory do not justify taking increasingly higher doses. Controlled studies and safety limits do not provide a basis for this. [8][11][12]
Sources and Further Information
- Finnish Vitamin D Trial, 2025: Vitamin D3 Supplementation and Newly Diagnosed Dementia. Retrieved October 28, 2026.
- Austrian Health Portal: Vitamin D—Requirements, Sources, and Deficiency. Retrieved October 28, 2026.
- Ghahremani et al. 2023: Vitamin D supplementation and incident dementia, NACC observational study. Retrieved October 28, 2026.
- VITAL Cognitive Studies 2021: Effect of Vitamin D on Cognitive Decline. Retrieved October 28, 2026.
- 2023 D-Health Study: Vitamin D Supplementation and Cognition. Retrieved October 28, 2026.
- Corbett et al. 2025: The VitaMIND RCT for Mild to Moderate Vitamin D Deficiency. Retrieved October 28, 2026.
- NICE PH56: Vitamin D Supplements for Specific Population Groups, Recommendation 7 on Screening. Retrieved October 28, 2026.
- Endocrine Society 2024: Vitamin D for Disease Prevention. Retrieved October 28, 2026.
- German Nutrition Society: Reference Values for Vitamin D. Retrieved October 28, 2026.
- Federal Institute for Risk Assessment: Vitamin D—Sunlight and Exercise Promote Adequate Intake. Retrieved October 28, 2026.
- EFSA 2023: Tolerable Upper Intake Level for Vitamin D. Retrieved October 28, 2026.
- NIH Office of Dietary Supplements: Vitamin D, Fact Sheet for Health Professionals. Retrieved October 28, 2026.
- NHS: How to Get a Dementia Diagnosis. Retrieved October 28, 2026.
- WHO, July 15, 2026: Updated Guidelines on Reducing the Risk of Dementia. Retrieved October 28, 2026.
Topic Overview: Complementary Approaches.
